The Centre has tightened rules for medicinal formulations containing over 12 per cent ethyl alcohol, requiring licences and prescription-only sales. The move aims to curb misuse, strengthen regulatory oversight, and ensure these medicines remain available solely for legitimate therapeutic purposes
